Benjamin (Beni) Gesundheit, MD PhD

CEO & Lead Scientist  

Dr. Gesundheit brings his experience in the departments of Pediatric Hematology-Oncology at the Hospital for Sick Children in Toronto Canada, the departments of Pediatric Hematology-Oncology at Soroka Hospital, Beer Sheva, Israel and at Hadassah Hospital, Jerusalem, Israel to his methodical research in ASD and its immunological aspects as well as to the rationale for treatment with stem cells. He holds a MD from the University of Basel,  Switzerland (1992). He received a PhD in Bioethics from University of Toronto (2004) with a dissertation on Jewish medical ethics. Dr. Gesundheit served on the faculty of the Department of Jewish Philosophy, Hebrew University of Jerusalem.

Ronald Ellis, PhD MBA

Chief Scientific Officer  

Dr. Ellis has 35 years of senior management experience for R&D companies – large, medium, small, startup and incubators. His development and project leadership skills have brought vaccines and therapeutics to the clinic and to the market.
Dr. Ellis holds a PhD Biology from Cornell University in New York (1979) and an MBA from the University of Maryland (1982) and is founding (2004) and current Editor-in-Chief of the international indexed journal Human Vaccines & Immunotherapeutics which publishes ~400 papers per year.

Leah Hochbaum, MA OTR/L

Recruitment Coordinator  

Mrs. Hochbaum has over 20 years of experience working with families of children with ASD. Leah speaks with parents and clinicians about our ASD diagnostic study, thereby enabling our research. Speak with Leah if you would like to join our team and work together at tackling the autism challenge. Leah holds a degree in BSc Biology from Touro College (1991) and an MA Occupational Therapy from New York University (1994).

Philip David Zisman, PhD

Immunologist and Laboratory Director  

Dr. Zisman has over ten years of experience in the fields of biotechnology, biochemistry, cell biology, immunology, and bioassays. He is responsible for laboratory expertise, assay development and international collaboration for lab related issues. Dr. Zisman holds a PhD in Microbiology from the Lautenberg Center for Immunology, Hebrew University Jerusalem (2005).

Yehudit Posen, PhD

Scientific Medical Writer  

Dr. Posen brings over ten years of medical and scientific writing experience with academic researchers and with the pharmaceutical and medical device industries. At Cell-El, she works on preparation of clinical trial-related documents and manuscripts for publication. Dr. Posen holds a PhD from the Department of Biological Regulation of the Weizmann Institute of Science (2006).

Baruch Labinsky, MA

Chief Business Officer  

Mr. Labinsky has extensive experience in working with companies in business, corporate and investment management. He is author of ‘A Financial Guide to Aliyah and Life in Israel’, founder of Labinsky Financial an investment management and financial planning firm, and is licensed by the Israel Securities Authority as an investment portfolio manager.  Mr. Labinsky is an MBA Honors graduate in Finance from the Schulich School of Business in Toronto. He is a member of the Society of Trust and Estate Practitioners (STEP) and is a Registered Trust and Estate Practitioner (TEP).

Susan Suna, MA

Web Development  

Mrs. Suna has over twenty years of web design and development experience with small to large organizations as well as pharmaceutical companies. She works closely with the team crafting the website and its messaging.